Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin D3 for Cardiometabolic Health in Chinese Adolescents
NCT07053657Completed
- Sponsor
- Anhui Medical University
- Start
- Sep 2025
- Primary completion
- Dec 2025
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Randomised, double-blind trial of cholecalciferol in Vitamin D deficiency (VDD) (2 arms), sponsored by Anhui Medical University. Primary endpoint: Change in cardiometabolic risk scores at 12 weeks. Started Sep 2025; status: completed.
02
Drugs
cholecalciferol
03
Conditions
Vitamin D deficiency (VDD)
Beyond the preview
Go deeper on NCT07053657.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07053657.